WLAC · Willow Lane Acquisition Corp.
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the liquidity condition, the date of mandatory liquidation and subsequent dissolution raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$325.36M
No Price Data
No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Limited
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-4% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
▲ +252.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
48 holders — mid 1-yr range
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WLAC
this stock
Willow Lane Acquisition Corp.
|
$325.36M | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$871.70M | — | — | — | 3.8% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$645.28M | +2.4% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$600.26M | +2.3% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Key facts
CIK
2032379
CUSIP
G9675P102